Imagine this: The FDA and the EMEA have asked you to meet specific requirements for your study. You need to ensure that you have participants sign an ICF indicating that they understand what they are getting into. Additionally, all participant-facing materials must be reviewed and approved by IRB/ERB before first use. All of this and more needs to be done before enrollment begins in a couple months. The list goes on and on and the amount of medical terminology, acronyms, and legal jargon increases. In the rush to hit important milestones and tick all the boxes to get from trial to market, many skip the important step of considering their audience, the so-what factor and delivering information with context and impact. Ultimately, when it comes to how and what you’re communicating, it may be clear to you; but, is it clear to others?

​

Your aim is to make advancements in the healthcare space. Yet, without participants, investors, and staff to execute research, how can progress be made? This is where placing value on the power and return of effective communications while conducting clinical research is essential. It is your first opportunity to make a good impression and build trust before going to market. You won’t be able to successfully bridge this gap without informed and committed key stakeholders, so don’t overlook this integral element to success.

​

Join Daniella McCrorie, Vice President Strategic Innovation with AXON Communications, to learn how to communicate effectively through plain language, empathy, and compelling narratives. You won’t want to miss it!